Skip to main content

Hoge Stephen's Form 4 filing

Moderna, Inc. (MRNA) · filed Jun 14, 2022

Accession no.
0001127602-22-017491
Filed
Jun 14, 2022
Trade date
Jun 13, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.23M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoge StephenCIK 0001760669Officer (President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 13, 2022Common StockMOption exerciseAcquired+5,000$10.90+$54,5001,629,231Direct
Jun 13, 2022Common StockMOption exerciseAcquired+5,000$10.90+$54,5001,634,231Direct
Jun 13, 2022Common StockSSaleDisposed−10,000$123.00−$1,230,0001,624,231Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 13, 2022Common StockMOption exerciseDisposed−5,000$0.00$061,972Direct
Jun 13, 2022Common StockMOption exerciseDisposed−5,000$0.00$056,972Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)